Aligos Therapeutics ALGS
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2024Q4 | 39.84 | 25.04 | -13.10 | -20,563 | -82 | |
| 2024Q3 | 8.66 | 105.02 | -3.09 | -20,131 | -19 | |
| 2024Q2 | 8.75 | 0.75 | -26,414 | 5 | ||
| 2024Q1 | 24.50 | -5.50 | -22,046 | -35 | ||
| 2023Q4 | 16.60 | 93.11 | 0.39 | -25,997 | -28 | |
| 2023Q3 | 18.68 | 105.88 | -10.34 | -19,071 | -18 | |
| 2023Q2 | 24.28 | -11.00 | -19,141 | -19 | ||
| 2023Q1 | 21.85 | -13.25 | -23,918 | -23 | ||
| 2022Q4 | 23.82 | 103.87 | -12.75 | -22,682 | -22 | |
| 2022Q3 | 27.50 | -11.00 | -18,948 | -19 | ||
| 2022Q2 | 30.25 | -11.50 | -20,393 | -20 | ||
| 2022Q1 | 53.75 | -21.00 | -35,557 | -36 | ||
| 2021Q4 | 296.75 | -22.75 | -37,948 | -38 | ||
| 2021Q3 | 387.75 | -19.50 | -33,069 | -33 | ||
| 2021Q2 | 509.63 | -19.75 | -29,564 | -30 | ||
| 2021Q1 | 568.50 | 100.40 | -18.50 | -27,740 | -28 | |
| 2020Q4 | 691.25 | 383.25 | -34,286 | -34 | ||
| 2020Q3 | -281.00 | -21,556 | -33 | |||
| 2020Q2 | -23.71 | -21,271 | -21 | |||
| 2020Q1 | -22.83 | -20,721 | -20 |